• FirefoxUpgrade to the new Firefox »
  •  Dow Up 2.43% Nasdaq Up 2.24%

    Arena Pharmaceuticals, Inc. (ARNA)

    -NasdaqGS
    4.04 0.14(3.59%) Dec 18, 4:00PM EST
    Add to Portfolio
    Prev Close:3.90
    Open:3.96
    Bid:3.40 x 4000
    Ask:4.90 x 10000
    1y Target Est:7.58
    Beta:-4.57
    Earnings Date:Feb 25 - Mar 2 (Est.)
    Day's Range:3.92 - 4.07
    52wk Range:3.26 - 7.97
    Volume:2,243,730
    Avg Vol (3m):3,834,300
    Market Cap:889.26M
    P/E (ttm):N/A
    EPS (ttm):-0.24
    Div & Yield:N/A (N/A)
    Quotes delayed, except where indicated otherwise. Currency in USD.

    Headlines

    » More Headlines for ARNA

    Comparison

    Symbol% ChgMkt Cap
    ARNAUp 3.59%889.26M
    GSK104.07B
    OREX774.71M
    RHHBY250.73B

    Key Statistics

    Forward P/E (1 yr):N/A
    P/S (ttm):25.03
    Ex-Dividend Date:N/A

    Analysts

    Annual EPS Est (Dec-14) :-0.24
    Quarterly EPS Est (Dec-14) :-0.11
    Mean Recommendation*:2.7
    PEG Ratio (5 yr expected):0.84

    * (Strong Buy) 1.0 - 5.0 (Sell)

    Analyst Opinion | Estimates

    Business Summary

    Arena Pharmaceuticals, Inc., a biopharmaceutical company, discovers, develops, and commercializes novel drugs that target G protein-coupled receptors. The company offers BELVIQ, a drug used to treat chronic weight management in adults. View More
    Your browser doesn't support canvas
    SETTINGS
    Scrolling
    Speed
    Display
    Price
    Submit Feedback